Although it was not cited, aminobenzoic acid may be linked to hypertension through one of its derivatives, Aminaftone, which suppresses the effects of pulmonary hypertension by downregulating endothelin-1 receptors (37). Here, EDNRA is linked to pulmonary arterial hypertension.